Atlas Trials

DLBCL Unclassifiable

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch DLBCL Unclassifiable

RecordFirmDate
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader (NCT05294731)BeiGene2022-05-06
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma (NCT04512716)Memorial Sloan Kettering Cancer Center2021-02-02

Track DLBCL Unclassifiable automatically

Every clearance here is in the API, with alerts when new ones post.